FDA Rips Aegerion Exec For Drug Promo Claims On CNBC
The U.S. Food and Drug Administration on Friday torched the CEO of Aegerion Pharmaceuticals Inc. for comments made on CNBC, saying viewers were left with the faulty impression that cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article